GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifecare ASA (OSL:LIFE) » Definitions » Institutional Ownership

Lifecare ASA (OSL:LIFE) Institutional Ownership : 6.49% (As of Jun. 07, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Lifecare ASA Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Lifecare ASA's institutional ownership is 6.49%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Lifecare ASA's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Lifecare ASA's Float Percentage Of Total Shares Outstanding is 0.00%.


Lifecare ASA Institutional Ownership Historical Data

The historical data trend for Lifecare ASA's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifecare ASA Institutional Ownership Chart

Lifecare ASA Historical Data

The historical data trend for Lifecare ASA can be seen below:

2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 7.61 7.44 7.44 6.50 6.50 6.49 6.49 6.49 6.49 6.49

Lifecare ASA Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Lifecare ASA (OSL:LIFE) Business Description

Traded in Other Exchanges
Address
Ytrebygdsvegen 215, Blomsterdalen, Bergen, NOR, 5258
Lifecare AS is engaged in the research and development of medical sensors for health monitoring. The company is engaged in the development, testing, and introduction of the first long-term implantable microsensor to give persons with diabetes a modern tool for the monitoring of glucose levels. It develops Sencell, a long-term implantable microsensor to give persons with diabetes a tool for monitoring of glucose levels.

Lifecare ASA (OSL:LIFE) Headlines

No Headlines